Beam Therapeutics Inc.

NAS: BEAM

GO
/marketstate/country/us

Market open

/zigman2/quotes/216229751/composite

$

33.01

Change

-1.98 -5.66%

Volume

Volume 392,801

May 24, 2022, 11:50 a.m.

Real time quotes

/zigman2/quotes/216229751/composite

Previous close

$ 34.99

$ 33.01

Change

-1.98 -5.66%

Day low

Day high

$31.67

$34.02

Open
Open: 33.97

52 week low

52 week high

$27.77

$138.52

Open

Market cap

$2.46B

Average volume

1.26M

P/E ratio

N/A

Rev. per Employee

$176,745

EPS

-3.61

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/beam

MarketWatch News on BEAM

  1. Luck Could Be Improving for the Battered Shares of Las Vegas Sands

    10:30 p.m. Jan. 14, 2022

    - Barron's Online

  2. Scientists Race to Make Really Big Changes to Your Genes

    3:23 p.m. Jan. 5, 2022

    - Barron's Online

  3. bluebird bio Has Good News on Its Gene Therapies

    1:16 p.m. Dec. 13, 2021

    - Barron's Online

  4. Beam Gets FDA Nod for First Gene-Editing Trial

    9:10 a.m. Nov. 9, 2021

    - Barron's Online

  5. Gene Therapy Is a Huge Opportunity. It Pays to be Patient.

    9:46 p.m. Nov. 5, 2021

    - Barron's Online

  6. Prime Is the Newest Gene Editing, and It's Getting Better

    7:11 p.m. Oct. 20, 2021

    - Barron's Online

  7. Beam Therapeutics assumed at buy, up from hold, at Stifel Nicolaus

    7:55 a.m. Sept. 24, 2021

    - Tomi Kilgore

  8. Intellia Stock Is Rocketing Because of a Gene-Editing Breakthrough

    9:21 a.m. June 30, 2021

    - Barron's Online

  9. Cathie Wood's ARK Innovation Is Rebounding. She Bought the Dip.

    2:39 p.m. May 28, 2021

    - Barron's Online

  10. Biotech stocks are a buy — especially these 18 picks

    2:02 p.m. March 13, 2021

    - Michael Brush

  11. Beam Therapeutics downgraded to neutral from overweight at J.P. Morgan

    8:18 a.m. Jan. 29, 2021

    - Tomi Kilgore

  12. Loading more headlines...
/news/nonmarketwatch/company/us/beam

Other News on BEAM

  1. The Correction In Biopharmaceutical Stocks Is Likely Over

    12:51 a.m. May 18, 2022

    - Seeking Alpha

  2. ARKG: Don't Expect Any Favorable Return In Short Or Medium Term

    10:06 a.m. May 11, 2022

    - Seeking Alpha

  3. 10-Q: BEAM THERAPEUTICS INC.

    7:36 a.m. May 9, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  4. Beam Therapeutics Q1 2022 Earnings Preview

    3:16 p.m. May 6, 2022

    - Seeking Alpha

  5. Beam Therapeutics Worth Watching Because Of Pfizer Interest?

    4:28 a.m. April 21, 2022

    - Seeking Alpha

  6. Beam Therapeutics: Getting More And More Interesting

    9:44 a.m. April 10, 2022

    - Seeking Alpha

  7. ARKK: Cathie Wood's Secret Selling

    11:10 a.m. March 31, 2022

    - Seeking Alpha

  8. The Commercial Potential Of Crispr In Light Of Patent Challenges

    8:36 a.m. March 22, 2022

    - Seeking Alpha

  9. Why Has ARKK Dropped Over 30% This Year And Where Is It Headed?

    10:30 a.m. March 11, 2022

    - Seeking Alpha

  10. Beam Therapeutics GAAP EPS of -$0.95, revenue of $51.07M

    7:51 a.m. Feb. 28, 2022

    - Seeking Alpha

  11. Family Management Corp Buys iShares Core S&P Total U.S. ...

    7:38 p.m. Feb. 17, 2022

    - GuruFocus.com

  12. Loading more headlines...
/news/pressrelease/company/us/beam

Press Releases on BEAM

  1. Wednesday's ETF Movers: COPX, ARKG

    1:13 p.m. Jan. 12, 2022

    - MarketNewsVideo.com

  2. Loading more headlines...

Rates »

Link to MarketWatch's Slice.